Filtered Listing Testing

Congratulations to Julianne Moore, star of “Still Alice,” on her “Best Actress” award at the Golden Globes. The film, which opens January 16, portrays the struggle of a college linguistics professor who experiences early Alzheimer’s.

BrightFocus 2013-14 grantee Crystal Miller, PhD, and her mentor, Bruce Lamb, PhD, both of the Cleveland Clinic, along with Taylor Jay of Case Western Reserve University, are coauthors on a new report that describes the surprising—even counterintuitive—role that a genetic variant associated with the immune system plays in Alzheimer’s disease (AD).

In his blog posted on March 17, National Institutes of Health Director Francis Collins asks a provocative question: “What Makes Our Brains Human?” He then provides at least a partial answer to that question with the help of some new science out of Yale.

Read about the success from an early clinical trial of the Alzheimer’s drug, aducanumab.

Last week, researchers in Iceland announced the completion of a large project to sequence the genomes (or complete DNA) of 2,636 of their fellow countrymen. The Icelandic data base is being called a “treasure trove” of information that will further scientists’ understanding of diseases that are not caused by one single genetic mutation, but instead to mutations on several different genes.

Good news from Yale—researchers there report early success using a still-experimental cancer drug known as saracatinib to treat Alzheimer’s disease in mice.

Read about recent research concerning evidence about the link between obesity and Alzheimer’s risk.

As the U.S population ages, Alzheimer's, glaucoma, macular degeneration, and other age-related diseases continue to pose a threat to American families. Resources are needed to propel research forward and find a cure.

In a study published by Nature Genetics, scientists have found insight into the cause of age-related macular degeneration.